Talent Acquisition Data and Analytics Intern at Eli Lilly and Company

Cork, County Cork, Ireland

Eli Lilly and Company Logo
Not SpecifiedCompensation
InternshipExperience Level
InternshipJob Type
UnknownVisa
Healthcare, PharmaceuticalsIndustries

Requirements

  • Currently enrolled in 3rd level education and ready to pursue student placement as part of an undergraduate/masters program
  • Proficiency in Excel, Power BI, Tableau, or similar data visualization tools
  • Experience with ATS (e.g., Taleo, Workday) and HRIS systems
  • Strong analytical and problem-solving skills
  • Excellent communication and presentation abilities
  • Ability to manage multiple projects and meet tight deadlines

Responsibilities

  • Collect and analyze data from ATS and other recruitment platforms
  • Maintain dashboards and reports on key metrics (e.g., time-to-fill, quality-of-hire etc)
  • Develop weekly and monthly reports for each manufacturing site in Europe/Asia
  • Identify trends and provide actionable insights to improve recruitment strategies
  • Support TA activities as needed
  • Present findings to stakeholders across HR and business units

Skills

Talent Acquisition
Data Analytics
HR Analytics
Excel
SQL

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI